Last reviewed · How we verify
NCT03195712
Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers
trial in Obesity in 691 participants. Completed in 30 September 2016.
30 September 2016
Quick facts
| Lead sponsor | St. Luke's-Roosevelt Hospital Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 691 |
| Start date | 4 September 2012 |
| Primary completion | 30 September 2016 |
| Estimated completion | 30 September 2016 |
| Sites | 1 location across United States |
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
St. Luke's-Roosevelt Hospital Center
Who can join
Adults 25 to 75, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study team's research fills the gap in the obesity literature where BMI with a cut point of 35 is frequently used to show the association between BMI and metabolic syndrome biomarkers. The study team was unable to locate any papers that showed the association between metabolic syndrome biomarkers and BMI from 35 to 69.9, and especially graphically as this clinical team has presented.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03195712
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other St. Luke's-Roosevelt Hospital Center trials
Trials by the same sponsor.
- NCT02159807 — Optimizing Dose of Bupivacaine in Combined Spinal Epidurals To Reduce Side Effects · NA · completed
- NCT00841451 — Pulmonary Vein Isolation Outcomes With Fish Oils · no longer available
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03195712 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Luke's-Roosevelt Hospital Center
- Last refreshed: 22 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03195712.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing